Piperacillin-Associated Immune Thrombocytopenia

Am J Ther. 2023 Sep-Oct;30(5):e505-e506. doi: 10.1097/MJT.0000000000001521. Epub 2022 May 25.

Authors

Leela Krishna Teja Boppana¹, Ahmed Elkhapery¹, Mindee Hite², Utsav Joshi¹, Nada Hafez¹, Michael Gurell³

Affiliations

¹ Department of Internal Medicine, Rochester General Hospital, Rochester, NY.
² Department of Pharmacy, Rochester General Hospital, Rochester, NY.
³ Department of Pulmonary and Critical Care Medicine, Rochester General Hospital, Rochester, NY.

PMID: 37713713
DOI: 10.1097/MJT.0000000000001521

No abstract available

MeSH terms

Anti-Bacterial Agents / adverse effects
Humans
Piperacillin / adverse effects
Purpura, Thrombocytopenic, Idiopathic* / chemically induced
Purpura, Thrombocytopenic, Idiopathic* / diagnosis
Purpura, Thrombocytopenic, Idiopathic* / drug therapy
Thrombocytopenia* / chemically induced
Thrombocytopenia* / diagnosis

Substances

Piperacillin
Anti-Bacterial Agents